NRF3 suppresses the malignant progression of TNBC by promoting M1 polarization of macrophages via ROS/HMGB1 axis
NRF3 promotes M1 macrophage polarization through the ROS/HMGB1 axis, thereby inhibiting the malignant progression of TNBC. It is expected to become a therapeutic biomarker for TNBC.
Authors
- Mingming Quan (ORCID: https://orcid.org/0009-0000-4411-0920)
- Ping Xing
- Bangyi Lin (ORCID: https://orcid.org/0000-0001-8833-9380)
- Zhenzhen Chen (ORCID: https://orcid.org/0000-0003-2093-4639)
- Wenbo Zhu (ORCID: https://orcid.org/0009-0000-2843-5813)
Institutions
- Wenzhou Medical University (CN)
- Taizhou Central Hospital (CN)
- Zhejiang Taizhou Hospital (CN)
- Taizhou University (CN)
Publication Details
- Journal
- Cancer Biology & Therapy
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1080/15384047.2024.2416221
- Citations
- 7
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Taizhou Municipal Science and Technology Bureau